Cadrenal Therapeutics, Inc.(CVKD)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
CVKD has no upcoming report date in the calendar yet. It last reported on May 7, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 10 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±7.2%).
Did the stock rise after good news?
The next-day move after each of its last 2 EPS beats and 6 misses.
- May '26Beat▼ -2.4%
- Mar '26Missed▲ +20.5%
- Nov '25Beat▼ -3.2%
- Aug '25Missed▼ -1.9%
- May '25Missed▼ -6.8%
- Mar '25Missed▲ +9.4%
- Nov '24Missed▲ +8.9%
- Aug '24Missed▲ +4.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did CVKD fall after beating earnings?
6 of CVKD's last 8 reactions went against the EPS result. What stands out in each:
CVKD beat EPS estimates in 2 quarters, and the stock still closed lower the next day 2 times.
- May 7, 2026EPS beat +33.8%stock -2.4% next day
- It had risen 27.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- Nov 10, 2025EPS beat +15.5%stock -3.2% next day
- It opened 5.2% lower as soon as trading resumed.
Rose despite an EPS miss (4 of 6)
- Mar 31, 2026EPS missed -16.5%stock +20.5% next day
- It had already fallen 50.5% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 1.9% higher as soon as trading resumed.
- Mar 13, 2025EPS missed -369.4%stock +9.4% next day
- It had already fallen 10.0% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 1.6% higher as soon as trading resumed.
- Nov 7, 2024EPS missed -21.1%stock +8.9% next day
- It had already fallen 4.0% in the final week before the report, so weak results may have been expected.
- It opened 1.2% higher as soon as trading resumed.
- Aug 7, 2024EPS missed -25.0%stock +4.6% next day
- It had already fallen 11.0% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was CVKD's earnings move already priced in?
CVKD's move in the month before each of its last 8 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 8 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does CVKD hold its opening gap after earnings?
CVKD's opening move after each report and where it closed that day.
In 7 reports CVKD opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. Gaps up faded 1 of 4; gaps down recovered 1 of 3.
- Mar 31, 2026HeldOpened +1.9%, closed +20.5%
- Nov 10, 2025HeldOpened -5.2%, closed -3.2%
- Aug 11, 2025HeldOpened -1.7%, closed -1.9%
- May 8, 2025ReversedOpened +3.0%, closed -6.8%
- Mar 13, 2025HeldOpened +1.6%, closed +9.4%
- Nov 7, 2024HeldOpened +1.2%, closed +8.9%
- Aug 7, 2024ReversedOpened -3.9%, closed +4.6%
CVKD earnings history
Last 10 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| May 7, 2026 | Before open | -$1.57 | -$1.04 | +33.8% | -2.43% | -10.49% |
| Mar 31, 2026 | Before open | -$1.21 | -$1.41 | -16.5% | +20.47% | +10.59% |
| Nov 10, 2025 | Before open | -$1.55 | -$1.31 | +15.5% | -3.17% | +0.78% |
| Aug 11, 2025 | Before open | -$1.77 | -$1.87 | -5.6% | -1.88% | +4.75% |
| May 8, 2025 | After close | -$1.64 | -$2.09 | -27.4% | -6.77% | -4.58% |
| Mar 13, 2025 | After close | -$1.86 | -$8.73 | -369.4% | +9.40% | +10.77% |
| Nov 7, 2024 | After close | -$1.80 | -$2.18 | -21.1% | +8.90% | +8.84% |
| Aug 7, 2024 | After close | -$1.80 | -$2.25 | -25.0% | +4.59% | +6.28% |
| May 9, 2024 | Before open | -$1.35 | -$1.50 | -11.1% | — | — |
| Mar 11, 2024 | Before open | -$1.35 | -$1.87 | -38.5% | — | — |
CVKD Earnings FAQ
Answers computed from Cadrenal Therapeutics, Inc.'s reported history
CVKD has no upcoming report date in the calendar yet. It last reported on May 7, 2026; companies usually report every three months.
Over the last 10 quarters with a usable EPS surprise, CVKD beat the consensus estimate 2 times (20%), missed 8 and landed in line 0.
Across its last 8 quarters with a measured reaction, CVKD moved an average of ±7.2% in the first session after reporting. It closed higher 50% of the time; the largest gain was 20.5% and the largest drop -6.8%.
Across its last 8 quarters with price data, CVKD moved an average of -2.6% in the 20 trading sessions before reporting and was higher in 38% of them. After a run-up of 3% or more (3 quarters), it fell the next day 67% of the time, averaging -0.1%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging +5.9%. This describes past reports; it is not a forecast.
In 7 reports CVKD opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · CVKD: 10 reported quarters, latest May 7, 2026. Information only, not investment advice.
Looking for more on CVKD?
Price charts, forecast, fundamentals and risk pages for CVKD are not on Tickzen yet. You can run a full stock analysis now.
Run the CVKD Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun